Local excision and radical excision for rectal gastrointestinal stromal tumors: a meta-analysis protocol.

Wenjun Luo, Chunyu Liu, Luyin Han, Haidong Zhang, Chaoyong Shen, Xiaonan Yin, Zhou Zhao, Mingchun Mu, Tianxiang Jiang, Zhaolun Cai, Bo Zhang
Author Information
  1. Wenjun Luo: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  2. Chunyu Liu: Department of Pharmacy, Evidence-based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.
  3. Luyin Han: Intensive Care Unit, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  4. Haidong Zhang: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  5. Chaoyong Shen: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  6. Xiaonan Yin: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  7. Zhou Zhao: Department of Gastrointestinal Cancer Center, Chongqing University Cancer Hospital, Chongqing, China.
  8. Mingchun Mu: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  9. Tianxiang Jiang: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  10. Zhaolun Cai: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  11. Bo Zhang: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.

Abstract

Background: To date, several studies have compared the surgical and oncological outcomes of local excision (LE) and radical excision (RE) for rectal gastrointestinal stromal tumors (GISTs), but some have limited numbers of small series. This protocol outlines the planned scope and methods for a systematic review and meta-analysis that will compare the surgical and oncological outcomes of LE and RE in patients with rectal GISTs.
Methods: This protocol is presented in accordance with the PRISMA-P guideline. PubMed, Embase, Web of Science, Cochrane Library and Wanfang database will be systematically searched. Furthermore, reference lists of all included articles will be screened manually to add other eligible studies. We will include randomized controlled trials (RCTs) and non-randomized studies (NRS) in this study. The primary outcomes evaluated will be R0 resection rate and disease-free survival, while the secondary outcomes will contain overall survival, length of stay, tumor rupture rate and complications. Two reviewers will independently screen and select studies, extract data from the included studies, and assess the risk of bias of the included studies. Preplanned subgroup analyses and sensitivity analyses are detailed within this protocol. The strength of the body of evidence will be assessed using GRADE.
Discussion: This review and meta-analysis will provide a comprehensive evaluation of the current evidence concerning the application of LE and RE in patients with rectal GISTs. The findings from this review will serve as a foundation for future research and emphasize the implications for clinical practice.
Systematic review registration: PROSPERO (CRD42017078338), https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=387409, PROSPERO CRD42017078338.

Keywords

References

  1. Cochrane Database Syst Rev. 2022 Nov 24;11:ED000160 [PMID: 36421032]
  2. J Clin Epidemiol. 2011 Apr;64(4):395-400 [PMID: 21194891]
  3. PLoS Med. 2009 Jul 21;6(7):e1000097 [PMID: 19621072]
  4. Clin Colon Rectal Surg. 2011 Sep;24(3):161-70 [PMID: 22942798]
  5. Ann Oncol. 2022 Jan;33(1):20-33 [PMID: 34560242]
  6. J Gastrointest Oncol. 2018 Apr;9(2):231-240 [PMID: 29755761]
  7. BMJ. 2016 Oct 12;355:i4919 [PMID: 27733354]
  8. Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142 [PMID: 31643080]
  9. Mol Clin Oncol. 2013 Jan;1(1):190-194 [PMID: 24649146]
  10. BMJ Open. 2020 Nov 4;10(11):e040282 [PMID: 33148760]
  11. Ann Transl Med. 2020 Mar;8(5):201 [PMID: 32309348]
  12. Transl Gastroenterol Hepatol. 2018 Feb 01;3:8 [PMID: 29552659]
  13. BMJ. 2016 Jul 21;354:i4086 [PMID: 27444514]
  14. J Surg Oncol. 2020 Dec;122(8):1639-1646 [PMID: 33184896]
  15. J Clin Epidemiol. 2011 Apr;64(4):380-2 [PMID: 21185693]
  16. Curr Opin Gastroenterol. 2019 Nov;35(6):555-559 [PMID: 31577561]
  17. Arch Surg. 2001 Apr;136(4):383-9 [PMID: 11296107]
  18. Syst Rev. 2021 Mar 29;10(1):89 [PMID: 33781348]
  19. J Gastrointest Oncol. 2019 Feb;10(1):144-154 [PMID: 30788170]
  20. Int J Surg. 2020 May;77:190-197 [PMID: 32278104]
  21. Syst Rev. 2021 Dec 6;10(1):306 [PMID: 34872603]
  22. Int J Surg. 2018 Aug;56:108-114 [PMID: 29920339]
  23. Ann Surg Oncol. 2017 May;24(5):1195-1201 [PMID: 28050726]
  24. BMJ. 2011 Oct 18;343:d5928 [PMID: 22008217]
  25. Ann Ital Chir. 2021 Apr 19;10: [PMID: 33875627]

Word Cloud

Created with Highcharts 10.0.0willstudiesexcisionrectaloutcomesprotocolreviewLEradicalREgastrointestinalstromalGISTsmeta-analysisincludedsurgicaloncologicallocaltumorspatientsratesurvivalanalysesevidencePROSPEROCRD42017078338Background:dateseveralcomparedlimitednumberssmallseriesoutlinesplannedscopemethodssystematiccompareMethods:presentedaccordancePRISMA-PguidelinePubMedEmbaseWebScienceCochraneLibraryWanfangdatabasesystematicallysearchedFurthermorereferencelistsarticlesscreenedmanuallyaddeligibleincluderandomizedcontrolledtrialsRCTsnon-randomizedNRSstudyprimaryevaluatedR0resectiondisease-freesecondarycontainoveralllengthstaytumorrupturecomplicationsTworeviewersindependentlyscreenselectextractdataassessriskbiasPreplannedsubgroupsensitivitydetailedwithinstrengthbodyassessedusingGRADEDiscussion:providecomprehensiveevaluationcurrentconcerningapplicationfindingsservefoundationfutureresearchemphasizeimplicationsclinicalpracticeSystematicregistration:https://wwwcrdyorkacuk/PROSPERO/display_recordphp?RecordID=387409Localtumors:GIST

Similar Articles

Cited By